Diality Inc closes $12.5 million in financing for portable hemodialysis machine
Click Here to Manage Email Alerts
Medical device developer Diality Inc. has closed $12.5 million in financing during a Series B investment round, according to a company press release.
The release noted the company is developing a “versatile hemodialysis system to address the unmet technology needs of the evolving dialysis industry,” with company CEO Osman Khawar, MD, explaining that dialysis delivery is becoming more “decentralized” as it shifts away from being primarily done at in-center facilities. This change is due, in part, to the COVID-19 pandemic, as well as increased costs and poor outcomes that have been demonstrated with in-center dialysis, according to Khawar.
“To accommodate cost-effective delivery outside of specialty dialysis facilities, hemodialysis machines need to be user friendly for non-specialty nurses, patients and care partners,” Khawar said in the release. “To meet the needs of prescribing physicians and their patients in acute, subacute and home settings, a portable machine also needs to be capable of delivering a wide range of dialysis doses. We see the lack of a machine with this level of versatility as a lingering market gap that we seek to fill by developing a truly portable system capable of delivering the intense dialysis doses commonly prescribed for patients receiving three dialysis treatments per week, in addition to lower-intensity doses suitable for more frequent dialysis.”
The release further noted that as the design of the hemodialysis system is now completed for clinical use, the initial Series B round of funding will be used in efforts to gain 510(k) clearance from the FDA.
Read more about
Click Here to Manage Email Alerts